Believe

Achieve

Pipeline


Indication (Target) Target Organ Compound Preclinical Phase 1 Phase 2 Phase 3
Alport syndrome (miR-21)
Orphan Disease
Kidney RG-012

Partner: Sanofi Genzyme

ADPKD (miR-17) Kidney RGLS4326

Cholestatic Diseases
(Undisclosed Targets)
Liver  
HCV backups (miR122) Liver  
NASH
(undisclosed targets)
Liver
Glioblastoma Multiforme (miR-10b) CNS

 

Indication (Target) Target Organ / Compound Phase
Alport syndrome (miR-21)
Orphan Disease
Kidney / RG-012 Ph2
Partner: Sanofi Genzyme
ADPKD (miR-17) Kidney / RGLS4326 PreClin
Cholestatic Diseases
(Undisclosed Targets)
Liver PreClin
HCV backups (miR122) Liver PreClin
NASH
(undisclosed targets)
Liver PreClin
Glioblastoma Multiforme (miR-10b) CNS PreClin